eLabNext
eLabNext is revolutionizing laboratories across the globe with innovative digital solutions designed for the future. Our Digital Lab Platform (DLP) integrates essential tools such as Electronic Lab Notebooks (ELN) and Laboratory Information Management Systems (LIMS), alongside cutting-edge technologies like artificial intelligence and machine learning. Engineered for effortless integration with your laboratory's existing hardware and software, this platform significantly boosts flexibility, security, and overall efficiency. By streamlining and optimizing your research and development processes within a secure and compliant framework, we enable researchers to focus more on driving innovation. Our dedicated team of experts is here to assist you throughout every phase of your digital lab transformation journey, ensuring a smooth transition. Additionally, eLabNext operates under the umbrella of Bio-ITech BV, which is affiliated with the Eppendorf Group.
Learn more
Stack AI
AI agents are designed to engage with users, answer inquiries, and accomplish tasks by leveraging data and APIs. These intelligent systems can provide responses, condense information, and derive insights from extensive documents. They also facilitate the transfer of styles, formats, tags, and summaries between various documents and data sources. Developer teams utilize Stack AI to streamline customer support, manage document workflows, qualify potential leads, and navigate extensive data libraries. With just one click, users can experiment with various LLM architectures and prompts, allowing for a tailored experience. Additionally, you can gather data, conduct fine-tuning tasks, and create the most suitable LLM tailored for your specific product needs. Our platform hosts your workflows through APIs, ensuring that your users have immediate access to AI capabilities. Furthermore, you can evaluate the fine-tuning services provided by different LLM vendors, helping you make informed decisions about your AI solutions. This flexibility enhances the overall efficiency and effectiveness of integrating AI into diverse applications.
Learn more
BIOiSIM
BIOiSIMTM is a revolutionary virtual drug development engine that offers significant advantages to the pharmaceutical industry by adeptly identifying drug compounds with strong potential for addressing specific diseases. Our range of translational solutions is designed to align with the unique requirements of your pre-clinical and clinical projects. At the heart of these offerings lies our trustworthy and validated BIOiSIMTM platform, which supports research on small molecules, large molecules, and viruses. Utilizing advanced models, this platform draws on data from thousands of compounds across seven different species, delivering a robustness that is rare in the industry. With a keen focus on human outcomes, it incorporates a translatability engine that efficiently translates insights between species. Importantly, the BIOiSIMTM platform is applicable before initiating preclinical animal trials, enabling earlier insights and significantly lowering costs linked to outsourced testing. This cutting-edge methodology not only improves efficiency but also hastens the overall drug development timeline, ultimately aiding the search for effective therapies. By streamlining the process, BIOiSIMTM has the potential to contribute to significant advancements in medicine.
Learn more
StarDrop
StarDrop™ is an all-encompassing software suite that offers cutting-edge in silico technology, all presented within an intuitive visual framework. By facilitating a smooth transition between up-to-date data, predictive modeling, and strategic decision-making for subsequent synthesis rounds, StarDrop™ enhances the discovery process's speed, efficiency, and overall productivity. Achieving a harmonious balance of various properties is crucial for the development of successful compounds. StarDrop™ effectively navigates the complexities of multi-parameter optimization, assisting users in identifying compounds with the greatest likelihood of success. Additionally, it conserves both time and resources by enabling the synthesis of fewer compounds and reducing the frequency of testing needed. As a result, researchers can focus their efforts more effectively, leading to more successful outcomes in their projects.
Learn more
